These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32510718)

  • 1. Proarrhythmic effect of automatic threshold testing algorithm in dual chamber devices.
    Larsen TR; Sargent D; Moyes M; Huizar JF; Tan AY; Ellenbogen KA; Kaszala K
    J Cardiovasc Electrophysiol; 2020 Aug; 31(8):2078-2085. PubMed ID: 32510718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proarrhythmic effects from competitive atrial pacing and potential programming solutions.
    Wass SY; Kanj M; Mayuga K; Hussein A; Saliba WI; Bhargava M; Cantillon D; Tchou PJ; Wazni O; Wilkoff BL; Chung MK
    Pacing Clin Electrophysiol; 2020 Jul; 43(7):720-729. PubMed ID: 32452039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial fibrillation reduces the atrial impedance amplitude during cardiac cycle: a novel detection algorithm to improve recognition of atrial fibrillation in pacemaker patients.
    Schmidt B; Asbach S; Schweika O; Zehender M; Bode C; Faber TS
    Europace; 2007 Sep; 9(9):812-6. PubMed ID: 17545214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Merits and limitations of the mode switching rate stabilization pacing algorithms in the implantable cardioverter defibrillator.
    Dijkman B; Wellens HJ
    J Interv Card Electrophysiol; 2001 Sep; 5(3):309-18. PubMed ID: 11500586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial Rate-Responsive Pacing and Incidence of Sustained Atrial Arrhythmias in Patients with Implantable Cardioverter Defibrillators.
    Fontenla A; Salguero R; Martinez-Ferrer JB; Rodriguez A; Alzueta J; Garcia E; Basterra N; Romero R; Concha JF; Viñolas X; Villacastin J; Lopez-Gil M; Arribas F
    Pacing Clin Electrophysiol; 2016 Jun; 39(6):548-56. PubMed ID: 27001125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between ventricular pacing and persistent atrial fibrillation in patients indicated to elective pacemaker replacement: Results of the Prefer for Elective Replacement MVP (PreFER MVP) randomized study.
    Ricci RP; Botto GL; Bénézet JM; Nielsen JC; De Roy L; Piot O; Quesada A; Quaglione R; Vaccari D; Mangoni L; Grammatico A; Kozák M;
    Heart Rhythm; 2015 Nov; 12(11):2239-46. PubMed ID: 26142300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First worldwide clinical experience with a new dual chamber implantable cardioverter defibrillator. Advantages and complications. The Ventak AV II DR investigators.
    Sticherling C; Schaumann A; Klingenheben T; Hohnloser SH
    Europace; 1999 Apr; 1(2):96-102. PubMed ID: 11233190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of pacing therapies for treating atrial tachyarrhythmias in patients with ventricular arrhythmias receiving a dual-chamber implantable cardioverter defibrillator.
    Adler SW; Wolpert C; Warman EN; Musley SK; Koehler JL; Euler DE
    Circulation; 2001 Aug; 104(8):887-92. PubMed ID: 11514374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study on the behavior of three different automatic mode switching dual chamber pacemakers to intracardiac recordings of clinical atrial fibrillation.
    Leung SK; Lau CP; Lam CT; Tse HF; Tang MO; Chung F; Ayers G
    Pacing Clin Electrophysiol; 2000 Dec; 23(12):2086-96. PubMed ID: 11202252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of advanced atrial pacing therapies for atrial tachyarrhythmias in patients with a new implantable dual chamber cardioverter-defibrillator.
    Gillis AM; Unterberg-Buchwald C; Schmidinger H; Massimo S; Wolfe K; Kavaney DJ; Otterness MF; Hohnloser SH;
    J Am Coll Cardiol; 2002 Nov; 40(9):1653-9. PubMed ID: 12427419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic and dual-site atrial pacing in the prevention of atrial fibrillation: The STimolazione Atrial DInamica Multisito (STADIM) Study.
    De Simone A; Senatore G; Donnici G; Turco P; Romano E; Gazzola C; Stabile G
    Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S71-4. PubMed ID: 17302722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience with the new detection algorithms for atrial fibrillation of a defibrillator with dual chamber sensing and pacing.
    Kühlkamp V; Dörnberger V; Mewis C; Suchalla R; Bosch RF; Seipel L
    J Cardiovasc Electrophysiol; 1999 Jul; 10(7):905-15. PubMed ID: 10413370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of autothreshold sensing and sinus rate on mode switching algorithm behavior.
    Wood MA; Ellenbogen KA; Dinsmoor D; Hess M; Markowitz T
    Pacing Clin Electrophysiol; 2000 Oct; 23(10 Pt 1):1473-8. PubMed ID: 11060867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of atrial fibrillation and flutter by a dual-chamber implantable cardioverter-defibrillator. For the Worldwide Jewel AF Investigators.
    Swerdlow CD; Schsls W; Dijkman B; Jung W; Sheth NV; Olson WH; Gunderson BD
    Circulation; 2000 Feb; 101(8):878-85. PubMed ID: 10694527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantable defibrillators configured for hybrid therapy of persistent and permanent atrial fibrillation: initial clinical experience with a novel lead system.
    Rao HB; Saksena S
    J Interv Card Electrophysiol; 2005 Aug; 13 Suppl 1():79-86. PubMed ID: 16133860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Worldwide clinical experience with a new dual-chamber implantable cardioverter defibrillator system.
    Schoels W; Swerdlow CD; Jung W; Stein KM; Seidl K; Haffajee CJ;
    J Cardiovasc Electrophysiol; 2001 May; 12(5):521-8. PubMed ID: 11386511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased base rate of atrial pacing for prevention of atrial fibrillation after implantation of a dual-chamber pacemaker: insights from the Atrial Overdrive Pacing Study.
    Kantharia BK; Freedman RA; Hoekenga D; Tomassoni G; Worley S; Sorrentino R; Steinhaus D; Wolkowicz JM; Syed ZA;
    Europace; 2007 Nov; 9(11):1024-30. PubMed ID: 17913697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of PR interval and pacing mode on persistent atrial fibrillation incidence in dual chamber pacemaker patients: a sub-study of the international randomized MINERVA trial.
    Boriani G; Pieragnoli P; Botto GL; Puererfellner H; Mont L; Ziacchi M; Manolis AS; Gulizia M; Tukkie R; Landolina M; Ricciardi G; Cicconelli M; Grammatico A; Biffi M
    Europace; 2019 Apr; 21(4):636-644. PubMed ID: 30649270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of rapid atrial pacing for termination of drug refractory atrial fibrillation: results of a dual chamber implantable cardioverter defibrillator trial.
    Gold MR; Leman RB; Euler DE
    Card Electrophysiol Rev; 2003 Dec; 7(4):341-4. PubMed ID: 15071249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.